SCHEMBL2162936

SCHEMBL2162936

CCCCCCCCC=CCCCCCCCC(=O)c1nncs1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 7/20 0.55
CES1 P23141 3/20 0.54
ALDH1A1 P00352 2/20 0.48
DUSP3 P51452 1/20 0.48
PTPN7 P35236 1/20 0.48
KDM4E B2RXH2 1/20 0.48
FFAR1 O14842 1/20 0.48
LMNA P02545 1/20 0.48
FABP3 P05413 1/20 0.48
CYP3A4 P08684 1/20 0.48
F7 P08709 1/20 0.48
CYP19A1 P11511 1/20 0.48
F3 P13726 1/20 0.48
FABP4 P15090 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
PTGS1 P23219 1/20 0.48
GNA15 P30679 1/20 0.48
PPARG P37231 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2162931 1.00 FAAH (0.55) FAAHCES1ALDH1A1DUSP3PTPN7
SCHEMBL3184482 1.00 FAAH (0.55) FAAHCES1ALDH1A1DUSP3PTPN7
SCHEMBL1668173 0.78 PLA2G4A (0.58) FAAHCES1
SCHEMBL1668176 0.78 PLA2G4A (0.58) FAAHCES1
SCHEMBL3184570 0.72 FAAH (0.64) FAAHCES1
SCHEMBL3184578 0.72 FAAH (0.64) FAAHCES1
SCHEMBL1952827 0.71 PLA2G4A (0.54) FAAHCES1ALDH1A1KDM4EFFAR1
Oleamide SCHEMBL8606302 0.71 FAAH (0.72) FAAHDUSP3PTPN7KDM4ELMNA
Oleamide SCHEMBL8606306 0.71 FAAH (0.72) FAAHDUSP3PTPN7KDM4ELMNA
SCHEMBL13662384 0.71 FAAH (0.62) FAAHCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2011-07-28 US disclosed
US-7662971-B2 enzyme inhibitor for treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE (US) 2010-02-16 US disclosed
WO-2010005572-A2 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2010-01-14 WO disclosed
EP-2093220-A2 Inhibitors of fatty acid amide hydrolase The Scripps Research Institute (US) 2009-08-26 EP disclosed
EP-1549624-B1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2009-05-13 EP disclosed
EP-1549624-A4 INHIBITORS OF FATTY ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2006-09-20 EP disclosed
US-20060111359-A1 enzyme inhibitor for treating sleep disorders THE SCRIPPS RESEARCH INSTITUTE (US) 2006-05-25 US disclosed
EP-1549624-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2005-07-06 EP disclosed
WO-2004033652-A2 INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2004-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111359-A1 enzyme inhibitor for treating sleep disorders FAAH, FAAH2, HCRTR2 FAAH 1/4885CES1 12/4885ALDH1A1 259/4885
US-20110183947-A1 ALPHA-KETO HETEROCYCLES AS FAAH INHIBITORS FAAH, FAAH2, FADS1 FAAH 1/4885CES1 11/4885ALDH1A1 170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.